TCG CROSSOVER MANAGEMENT, LLC MoonLake Immunotherapeutics Transaction History

TCG CROSSOVER MANAGEMENT, LLC portfolio value:

$7.76M
portfolio value

TCG CROSSOVER MANAGEMENT, LLC quarter portfolio value change:

+47.81%
quarter

MoonLake Immunotherapeutics 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share 0.00% 0 shares 2.51M $7.76 1M
Q2 2022 share Increase 0.00% 1M shares 5.25M $5.25 1M